Abstract
Since 1968 (1) it has been known that lipoprotein abnormalities often develop in patients on maintenance hemodialysis (2,3) and in recipients of successful renal homo-transplants (3). As high as 50% mortality from premature cardiovascular disease has been reported in chronic dialysis patients. This report documents the incidence, type and natural history of hyperlipoproteinemia (HLP) occurring in patients on hemodialysis and with renal transplants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bagdade, J.D., et al, New Engl. J. Med. 279:181, 1968
Bagdade, J.D., Ked. Int. 7:S-370, 1975
Lazarus, J.M., et al, Ked. Int. 7:S-167, 1975
Carr, J., Drekter, J., Clinical Chemistry 2, Oct 1956
Bucolo, G., David, H., Clinical Chemistry 19, p476, 1973
Frederickson, D., et al, New Engl. J. Med. 276, p34, 1967
Frederickson, D., et al, Adv. Exper. Med. Biology 4:307, 1969
Brunner, F.P., et al, Proc. Europ. Dialysis Trans. Assoc. 9:3, 1972
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Bear, R.A., Lee, R., Shainhouse, Z., Buckley, G. (1977). Hyperlipoproteinemia in Chronic Hemodialysis Patients and Long-Term Renal Transplant Recipients. In: Manning, G.W., Haust, M.D. (eds) Atherosclerosis. Advances in Experimental Medicine and Biology, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4220-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4220-5_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4222-9
Online ISBN: 978-1-4613-4220-5
eBook Packages: Springer Book Archive